Clinical Trials July 28, 2026
Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial
This article from MedCity News covers: Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial.
Source: MedCity News • Editorial summary by GLP-1 Price Guide
What This Means for You
This article from MedCity News covers: Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial.
This article from MedCity News covers: Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial.
Source: MedCity News
Original source
Read the full article at MedCity News